Singapore is currently observing a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 143.86 million, marking a decrease of 13.33 million (-8.5%) compared to 2012.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Singapore
No matching regions
Similar regions to Singapore
More indicators for Singapore
Higher-education-finacing R&D financed by general university in local currency
0.00M
0.00M
(2020)
R&D financed by rest of the world in local currency
4,610.70M
-403.20M
(2020)
Government R&D financed by rest of the world in local currency
144.70M
+14.70M
(2020)
Business R&D financed by rest of the world in local currency
4,108.50M
-489.00M
(2020)
Singapore Business R&D pharmaceutical in constant PPP $ between 1994 and 2013
| Period | Value | Change |
|---|---|---|
| 2013 | 143.86M | -13.33M |
| 2012 | 157.18M | +19.61M |
| 2011 | 137.57M | +8.71M |
| 2010 | 128.86M | +35.02M |
| 2009 | 93.84M | +54.82M |
| 2008 | 39.01M | -117.30M |
| 2007 | 156.31M | -170.33M |
| 2006 | 326.64M | +241.01M |
| 2005 | 85.62M | +29.22M |
| 2004 | 56.40M | -14.72M |
| 2003 | 71.11M | +7.22M |
| 2002 | 63.89M | +35.88M |
| 2001 | 28.01M | -1.88M |
| 2000 | 29.89M | +4.38M |
| 1999 | 25.50M | -0.96M |
| 1998 | 26.47M | +13.61M |
| 1997 | 12.86M | +4.42M |
| 1996 | 8.44M | -0.46M |
| 1995 | 8.90M | -13.70M |
| 1994 | 22.60M |